✨ Free AI Report
scPharmaceuticals Inc.: Key Facts, Business Model & Financial Analysis Read the overview below or get the full interactive report with Cyborg Score, analyst debate audio & saved-company playlists — free, no credit card.
Get Free Report →
Home Company Research scPharmaceuticals Inc.
Company Research

scPharmaceuticals Inc.: Business Overview, Financials & Competitive Analysis

scPharmaceuticals is a pharmaceutical company focused on developing and commercializing products to optimize the delivery of infused therapies, advance patient care and reduce healthcare costs. Its commercial product,...

Analyst-debate audio for scPharmaceuticals Inc.

AskCyborg analysts argue the bull and bear cases for scPharmaceuticals Inc. across 11 stress-tested dimensions. Listen on your commute -- faster than reading the 30-page report.

Play the free intro →
Free intro · Pro unlocks the full analyst debate
5/ 10Mixed

Cyborg Score thesis

Novel subcutaneous delivery platform with strong growth trajectory, but limited upside as acquired subsidiary pending...

Read the full analyst-debate transcript →
Industry Specialty Pharmaceuticals / Drug Delivery Systems
1 named competitors
3 recent developments
11 analyst dimensions
Synthesized from analyst-debate stress-testing across 11 dimensions and hundreds of data points. Methodology →
Cyborg Score recalibrated: October 19, 2026
AI-Generated Research
30+ Page Report

Get the Latest scPharmaceuticals Inc. Report

Up-to-date AI-powered research, analyst debate audio & saved-company playlists

Get Current Report Free
✓ No credit card required
or get it by email

scPharmaceuticals Inc. Overview

Pro stress-test →

scPharmaceuticals is a pharmaceutical company focused on developing and commercializing products to optimize the delivery of infused therapies, advance patient care and reduce healthcare costs. Its commercial product, FUROSCIX, consists of furosemide delivered via an on-body infuser.

Strategic Profile

Pro stress-test →

The company's strategy is to develop therapies for subcutaneous administration that have previously been limited to intravenous (IV) delivery. MannKind Corporation has completed its acquisition of scPharmaceuticals, with scPharmaceuticals showing impressive revenue growth of 107.79% over the last twelve months.

Competitive Landscape

Pro stress-test →

scPharmaceuticals operates in the specialized drug delivery market, competing with other companies developing subcutaneous administration technologies. The acquisition by MannKind positions it within a larger pharmaceutical ecosystem focused on innovative delivery mechanisms.

Industry Context

scPharmaceuticals Inc. operates in Specialty Pharmaceuticals / Drug Delivery Systems.

Key facts

Revenue: 107.79% growth (LTM)

What the AI analysts debated

AI-generated and not independently verified: selected findings from the multi-agent debate on scPharmaceuticals Inc..

  • MannKind Corporation completed its acquisition of scPharmaceuticals in October 2025.
  • Company maintained a healthy current ratio of 3.85, indicating strong short-term liquidity position.
+2 more AI-generated counter-arguments unlock with Pro. Read the full analyst debate →

Recent developments

Material events tracked by the AskCyborg corpus.

  • October 2025MannKind completed acquisition of scPharmaceuticals
  • October 2025Stock delisted from NASDAQ Global Select Market
  • +1 moreTrack every material event for scPharmaceuticals Inc. as it happens. Explore monitoring →
Get alerted when scPharmaceuticals Inc. has a new material development →

Named competitors

Pulled from the analyst-debate framework. Click any competitor to see their Cyborg Score.

Subcutaneous Delivery DevicesAlternative IV-to-subcutaneous conversion technologies→

Compare scPharmaceuticals Inc. with another company

Pick any company in the AskCyborg corpus to see side-by-side Cyborg Scores and insights.

vs
Side-by-side opens in your AskCyborg account

Industry context

scPharmaceuticals Inc. operates in Specialty Pharmaceuticals / Drug Delivery Systems. See how the rest of the sector scores on the Cyborg framework.

Top companies in Specialty Pharmaceuticals by Cyborg Score

Browse Specialty Pharmaceuticals / Drug Delivery Systems research →
NEW · MCP server

Ask your AI assistant about scPharmaceuticals Inc.

Install the free AskCyborg MCP server in Claude, Cursor, Cline, Continue, or Windsurf and ask any of these in-line:

“Compare scPharmaceuticals Inc. and its top competitor on Cyborg Score”
“What did scPharmaceuticals Inc. do this quarter?”
“Is scPharmaceuticals Inc. a defensible business in 5 years?”
Install the MCP server (10 sec) →
Free, anonymous, no API key required

How AskCyborg research is made

⚔

AI analyst debate, not single-author opinion

Every report is generated by a panel of AI analysts arguing across 11 dimensions, so counter-arguments sit alongside the case. The debate is a reasoning process; it does not independently verify facts.

📊

Dated, not live

The Cyborg Score and recent developments reflect public sources as of the date shown and can miss or lag recent events. Check primary sources before relying on them.

🔗

Methodology open at /methodology

The framework, dimensions, and band breakdowns are documented. The Cyborg Score is an AI-generated opinion under that framework, not a credit rating or an investment recommendation.

🔒

Free tier is free

No credit card to read the research. Pro adds saved-company audio playlists, monitoring, audio briefings on demand, and PDF export for $39/mo annual.

Sources: public filings, regulatory data, and news flow, analysed by AI models. Read the methodology →

AI-generated research summary based on public sources; it may contain errors or omissions. Not investment advice. Not reviewed or endorsed by the companies covered. Report an error: legal@askcyborg.com · Terms of Service

Frequently asked questions

What does scPharmaceuticals Inc. do?+
scPharmaceuticals is a pharmaceutical company focused on developing and commercializing products to optimize the delivery of infused therapies, advance patient care and reduce healthcare costs. Its commercial product,...
What is scPharmaceuticals Inc.'s Cyborg Score?+
scPharmaceuticals Inc. has a Cyborg Score of 5/10 (Mixed). The score synthesizes business model, financials, leadership, competitive position, technology, marketing, and ESG dimensions across hundreds of data points.
Who are scPharmaceuticals Inc.'s main competitors?+
Named competitors include Subcutaneous Delivery Devices. The full competitive landscape is in the AskCyborg report.
How can I get the full scPharmaceuticals Inc. research report?+
Get the report plus analyst-debate audio at askcyborg.com -- no credit card required for preview access. Pro adds saved-company audio playlists and monitoring.
How current is the scPharmaceuticals Inc. research?+
The Cyborg Score is recalibrated weekly. Recent developments are tracked continuously and surfaced in every report.

Track scPharmaceuticals Inc. over time

Pro members get saved-company audio playlists, Cyborg Score recalibrations, and monitoring for material events across the AskCyborg corpus.

See Pro features
From $39/mo annual

More Specialty Pharmaceuticals research

Companies in the same sector and named competitors, ranked by Cyborg Score.

8Catalyst Pharmaceuticals, Inc.7Achieve Life Sciences, Inc.7Assertio Holdings, Inc.7Viatris Inc.7Xeris Biopharma Holdings, Inc.6Allergy Therapeutics PLC6Eagle Pharmaceuticals Inc.6Santhera Pharmaceuticals Holding AG6Supernus Pharmaceuticals, Inc.5Amphastar Pharmaceuticals, Inc.Top companies in Specialty Pharmaceuticals by Cyborg Score